LEVOMECOR Trademark

Trademark Overview

On Thursday, March 31, 2022, a trademark application was filed for LEVOMECOR with the United States Patent and Trademark Office. The USPTO has given the LEVOMECOR trademark a serial number of 97341540. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, May 28, 2024. This trademark is owned by PLMRD MIAMI, LLC. The LEVOMECOR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research services
levomecor

General Information

Serial Number97341540
Word MarkLEVOMECOR
Filing DateThursday, March 31, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, May 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2022

Trademark Statements

Goods and ServicesPharmaceutical research services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 6, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePLMRD MIAMI, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMiami Beach, FL 33139
Party NamePLMRD MIAMI, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMiami Beach, FL 33139

Trademark Events

Event DateEvent Description
Wednesday, April 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 4, 2022NEW APPLICATION ENTERED
Monday, April 25, 2022ASSIGNED TO EXAMINER
Monday, April 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 11, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 26, 2022NOTICE OF ALLOWANCE CANCELLED
Monday, October 17, 2022NEW NOA TO ISSUE
Tuesday, May 31, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 31, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, July 28, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, April 23, 2023SOU TEAS EXTENSION RECEIVED
Sunday, April 23, 2023SOU EXTENSION 1 FILED
Sunday, April 23, 2023SOU EXTENSION 1 GRANTED
Tuesday, April 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 27, 2023SOU EXTENSION 2 FILED
Monday, November 27, 2023SOU EXTENSION 2 GRANTED
Wednesday, November 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 28, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 28, 2024SOU EXTENSION 3 FILED
Tuesday, May 28, 2024SOU EXTENSION 3 GRANTED
Wednesday, May 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 27, 2023SOU TEAS EXTENSION RECEIVED

Related Keywords

levomecor services research pharmaceutical